These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29903099)

  • 21. Association between serum uric acid, high sensitive C-reactive protein and pro-oxidant-antioxidant balance in patients with metabolic syndrome.
    Ahmadnezhad M; Arefhosseini SR; Parizadeh MR; Tavallaie S; Tayefi M; Darroudi S; Ghazizadeh H; Moohebati M; Ebrahimi M; Heidari-Bakavoli A; Azarpajouh MR; Ferns GA; Mogharebzadeh V; Ghayour-Mobarhan M
    Biofactors; 2018 May; 44(3):263-271. PubMed ID: 29638023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperferritinemia increases the risk of hyperuricemia in HFE-hereditary hemochromatosis.
    Flais J; Bardou-Jacquet E; Deugnier Y; Coiffier G; Perdriger A; Chalès G; Ropert M; Loréal O; Guggenbuhl P
    Joint Bone Spine; 2017 May; 84(3):293-297. PubMed ID: 27659401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperuricemia as a Protective Factor for Mild Cognitive Impairment in Non-Obese Elderly.
    Wang F; Zhao M; Han Z; Li D; Zhang S; Zhang Y; Kong X; Sun N; Zhang Q; Lei P
    Tohoku J Exp Med; 2017 May; 242(1):37-42. PubMed ID: 28529242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Investigation on the prevalence of hyperuricemia among young students].
    Xie LF; Zhao W; Zhong YC; Wang DL; Zhang XW
    Zhonghua Yi Xue Za Zhi; 2018 Apr; 98(13):987-991. PubMed ID: 29690707
    [No Abstract]   [Full Text] [Related]  

  • 25. Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin.
    González AS; Guerrero DB; Soto MB; Díaz SP; Martinez-Olmos M; Vidal O
    Eur J Clin Nutr; 2006 Jun; 60(6):802-9. PubMed ID: 16493453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Association of metabolic syndrome with serum interleukin-10 and high sensitive C reactive protein(hs-CRP) in old men].
    Chen LX; Zhang SD; Zhu LL; Sun M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 33(10):970-4. PubMed ID: 19001743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can high-sensitivity C-reactive protein and ferritin predict functional outcome in acute ischemic stroke? A prospective study.
    Ozkan AK; Yemisci OU; Saracgil Cosar SN; Oztop P; Turhan N
    Top Stroke Rehabil; 2013; 20(6):528-36. PubMed ID: 24273300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
    Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of Hyperuricemia and its Correlation with Serum Lipids and Blood Glucose in Physical Examination Population in 2015 - 2018: a Retrospective Study.
    Yang WX; Ma Y; Hou YL; Wang YB; You CG
    Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of cardiovascular risk factors and serum ferritin with C-reactive protein.
    Sung KC; Kang JH; Shin HS
    Arch Med Res; 2007 Jan; 38(1):121-5. PubMed ID: 17174735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of plasma apolipoprotein CIII, high sensitivity C-reactive protein and tumor necrosis factor-α contributes to the clinical features of coronary heart disease in Li and Han ethnic groups in China.
    Chen L; Sun M; Liu H; Ma L; Wang T; Li P; Lin M; Lin H; Chang P; Liu Y
    Lipids Health Dis; 2018 Jul; 17(1):176. PubMed ID: 30053815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated levels of ferritin and hs-CRP in type 2 diabetes.
    Alam F; Fatima F; Orakzai S; Iqbal N; Fatima SS
    J Pak Med Assoc; 2014 Dec; 64(12):1389-91. PubMed ID: 25842584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of serum uric acid with high-sensitivity C-reactive protein in postmenopausal women.
    Raeisi A; Ostovar A; Vahdat K; Rezaei P; Darabi H; Moshtaghi D; Nabipour I
    Climacteric; 2017 Feb; 20(1):44-48. PubMed ID: 28105870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity, plasma high sensitivity C-reactive protein levels and insulin resistance status among school children in Taiwan.
    Wu DM; Chu NF; Shen MH; Wang SC
    Clin Biochem; 2006 Aug; 39(8):810-5. PubMed ID: 16814764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study on the levels of uric acid and high-sensitivity C-reactive protein in ACS patients and their relationships with the extent of the coronary artery lesion.
    Ma QQ; Yang XJ; Yang NQ; Liu L; Li XD; Zhu K; Fu Q; Wei P
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4294-4298. PubMed ID: 27831644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of high-sensitivity C-reactive protein in middle-aged and elderly Chinese people with hyperuricaemia and risk of coronary heart disease: a cross-sectional study.
    Xie M; Xie D; Yang Y; Zhang Y; Li K; Zhou B; Yang Z; Ding X; Li H
    BMJ Open; 2019 Oct; 9(10):e028351. PubMed ID: 31630099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between serum uric acid level and hypertension in a Chinese elderly rural population.
    Wu L; He Y; Jiang B; Liu M; Wang J; Zhang D; Wang Y; Zeng J
    Clin Exp Hypertens; 2017; 39(6):505-512. PubMed ID: 28722540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Association of serum uric acid, plasma NT-proBNP, Hs-C reactive protein and invasive hemodynamic parameters in patients with heart failure].
    Zhang YH; Lü R; Zhao XY; Kang LM; Yang YJ; Zhang J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Feb; 37(2):126-9. PubMed ID: 19719987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum uric acid can predict higher C-reactive protein levels in apparently healthy men.
    de Carvalho Vidigal F; de Lima Rosado LE; Paixão Rosado G; Lanes Ribeiro Rde C; Castro Franceschini Sdo C
    Nutr Hosp; 2014 Apr; 29(4):935-40. PubMed ID: 24679039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Placebo-controlled double-blind dose-response study of the non-purine-selective xanthine oxidase inhibitor febuxostat (TMX-67) in patients with hyperuricemia (including gout patients) in japan: late phase 2 clinical study.
    Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S35-43. PubMed ID: 21654268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.